• Home
  •  
    Regions
    • Europe
    • UK & Ireland
    • DACH
    • Nordic
    • France
    • Southern Europe
    • Benelux
    • CEE
    • Asia
  •  
    Deals
    • Buyouts
    • Venture
    • Exits
    • Refinancings
    • Build-up
    • Turnaround
    • Secondaries
    • Advanced deals search
  •  
    Funds
    • Buyout
    • Venture
    • Mezzanine
    • Debt
    • Funds-of-funds
    • Secondaries
    • Fundraising pipelines
    • Advanced funds search
  •  
    GPs & LPs
    • GP profiles
    • LP profiles
    • GP news
    • LP news
    • Sponsors search
    • LPs search
  •  
    Secondaries
    • Deals
    • Funds
    • News
    • Analysis
  •  
    People
    • People moves
    • Analysis
    • In Profile
    • Q&A
    • Videos
    • Comment
  •  
    Analysis
    • In Profile
    • Fundraising
    • Q&A
    • Comment
    • Videos
    • Podcast
    • Reports
    • Data Snapshots
  •  
    Unquote Data
    • Deals search
    • Exits search
    • Funds search
    • Sponsors search
    • Advisers search
    • LPs search
    • League tables
    • Reports
  • Sign in
  • Sign in
    • You are currently accessing unquote.com via your Enterprise account.

      If you already have an account please use the link below to sign in.

      If you have any problems with your access or would like to request an individual access account please contact our customer service team.

      Phone: +44 (0)203 741 1137

      Email: Georgina.Lawson@acuris.com

      • Sign in
     
      • Newsletters
      • Account details
      • Contact support
      • Sign out
     
  • Follow us
    • Twitter
    • LinkedIn
  • Free Trial
  • Subscribe
Unquote
Unquote
  • Home
  • Regions
  • Deals
  • Funds
  • GPs & LPs
  • Secondaries
  • People
  • Analysis
  • Unquote Data
  • You are currently accessing unquote.com via your Enterprise account.

    If you already have an account please use the link below to sign in.

    If you have any problems with your access or would like to request an individual access account please contact our customer service team.

    Phone: +44 (0)203 741 1137

    Email: Georgina.Lawson@acuris.com

    • Sign in
 
    • Newsletters
    • Account details
    • Contact support
    • Sign out
 

Healthcare

Biotechnology
PE-backed Wilson Therapeutics in SEK 7.1bn trade sale

Alexion Pharmaceuticals announces a public cash offer to acquire Wilson for SEK 232 per share

  • Exits
  • 12 April 2018
Dental implants and dentures
Adiuva Capital-backed AC Dental buys NT Dental

Adiuva generally makes investments between €5-40m for majority and minority positions

  • Expansion
  • 12 April 2018
Child welfare and adoption services
Folmer exits Jatkopolut to Familar

Familiar is a subsidiary of healthcare and social services firm Mehiläinen, backed by Triton and KKR

  • Exits
  • 12 April 2018
Dentures and dentistry
Capvis, Partners Group buy Amann Girrbach from TA

Capvis draws equity from its new DACH-focused buyout fund Capvis Equity V, targeting €1bn

  • Buyouts
  • 11 April 2018
Computer animation of DNA strand
Benelux's biotech and pharma buyouts market in rude health

Buyout houses are becoming more attracted to assets in the Benelux biotech and pharma spaces, typically the preserve of venture capital investors

  • Benelux
  • 11 April 2018
Biotechnology and medical sciences
Investindustrial acquires Lifebrain

Lifebrain was initially funded with capital raised from several Austrian private investors

  • Buyouts
  • 09 April 2018
Surgery tools and medical devices
ArchiMed buys Soest Medical

GP draws equity from its €315m Med II vehicle, which held a final close on its hard-cap in September

  • Buyouts
  • 09 April 2018
Simcro manufactures injectors for veterinarians
CDPQ-backed Datamars acquires Simcro from Riverside

Deal brings a five-year holding period for private equity firm The Riverside Company to an end

  • Portfolio management
  • 06 April 2018
Healthcare data
Tesi, Debiopharm lead €4.4m series-A for Kaiku Health

Finnish growth investor Prodeko Ventures participated in the round, alongside existing investors

  • Early-stage
  • 06 April 2018
Laboratory blood and DNA testing
Connection Capital backs HEL

Connection Capital invests £5.9m in the UK-based lab equipment manufacturer to boost growth

  • Expansion
  • 04 April 2018
Keyhole surgery tools
Main Capital-backed RVC buys Allgeier

Combined group will operate under the name RVC Medical IT and targets revenues of €10m for 2018

  • Expansion
  • 04 April 2018
Orthopaedic medicine
Apposite acquires OrthoD from The Riverside Company

Deal is the fifth investment for healthcare-focused GP Apposite's latest vehicle

  • Buyouts
  • 29 March 2018
Health apps and diagnosis software
Qiming in $12m series-A for LetsGetChecked

Healthcare self-testing company will invest in technology development and recruitment

  • Expansion
  • 29 March 2018
MedPharm is a contract drug developer
Ampersand invests in MedPharm

UK-headquartered provider of drug-related products and devices will look to expand internationally

  • Buyouts
  • 27 March 2018
Medication and pharmaceutical products
G Square backs Pharmacy2U

Following the investment, G Square will become Pharmacy2U's majority shareholder

  • Expansion
  • 26 March 2018
Laboratory blood and DNA testing
Ardian sells Groupe Bio7 to trade

Buyer Cerba HealthCare is owned by Partners Group and Canadian pension fund PSP Investments

  • Exits
  • 26 March 2018
Healthcare drugs and digestion assistance prescriptions
Sofinnova leads €6m series-A for SafeHeal

Fresh capital will be used to develop a clinical and regulatory market access programme for Colovac

  • Early-stage
  • 26 March 2018
Cattle farming and animal husbandry
Seventure holds first close on €24m

France-based animal nutrition specialist Adisseo is among Seventure's AVF fund investors

  • Funds
  • 22 March 2018
Spectacles and opticians
BGF divests Duncan & Todd as part of LDC-led SBO

Opticians group will pursue an acquisitive growth strategy under LDC's ownership

  • Exits
  • 21 March 2018
Tumour analysis and biotechnology
Principia leads €10m series-A for CheckMab

GP deploys capital from its healthcare-dedicated vehicle Principia III to finance the investment

  • Early-stage
  • 21 March 2018
New players are heralding a return to traditional values
GIC in £100m round for Oxford Nanopore

Deal gives the UK-based gene-sequencing devices company an equity valuation of £1.5bn

  • Expansion
  • 21 March 2018
Biotechnology and medical sciences
VC firms sell Prexton to Lundbeck for up to €905m

Vendors include Sunstone Capital, Ysios Capital Partners and Forbion Capital Partners

  • Exits
  • 19 March 2018
Eye test and opthalmology centres
Palamon makes 3.6x on sale of Ober Scharrer to Nordic Capital

Sale is the 16th realisation from Palamon’s 2006-vintage fund, Palamon European Equity II

  • Buyouts
  • 13 March 2018
Fundraising in pounds sterling
NCL Technology Ventures launches £50m fund

Fund will invest in high-growth SMEs, with a focus on medical technologies and therapeutics

  • Funds
  • 13 March 2018
52 53 54
  • About Unquote
  • Advertise
  • Contacts
  • About Acuris
  • Terms of Use
  • Privacy Policy
  • Group Disclaimer
  • Twitter
  • LinkedIn

© Merger Market

© Mergermarket Limited, 10 Queen Street Place, London EC4R 1BE - Company registration number 03879547

Digital publisher of the year 2010 & 2013

Digital publisher of the year 2010 & 2013